Ranking the contribution of behavioral measures comprising oxycodone self-administration to reinstatement of drug-seeking in male and female rats.
escalation
female
front-loading
opioid
relapse
sex difference
vulnerability
Journal
Frontiers in behavioral neuroscience
ISSN: 1662-5153
Titre abrégé: Front Behav Neurosci
Pays: Switzerland
ID NLM: 101477952
Informations de publication
Date de publication:
2022
2022
Historique:
received:
02
09
2022
accepted:
04
11
2022
entrez:
12
12
2022
pubmed:
13
12
2022
medline:
13
12
2022
Statut:
epublish
Résumé
Rates of relapse to drug use during abstinence are among the highest for opioid use disorder (OUD). In preclinical studies, reinstatement to drug-seeking has been extensively studied as a model of relapse-but the work has been primarily in males. We asked whether biological sex contributes to behaviors comprising self-administration of the prescription opioid oxycodone in rats, and we calculated the relative contribution of these behavioral measures to reinstatement in male and female rats. Rats were trained to self-administer oxycodone (8 days, training phase), after which we examined oxycodone self-administration behaviors for an additional 14 days under three conditions in male and female rats: short access (ShA, 1 h/d), long access (LgA, 6 h/d), and saline self-administration. All rats were then tested for cue-induced reinstatement of drug-seeking after a 14-d forced abstinence period. We quantified the # of infusions, front-loading of drug intake, non-reinforced lever pressing, inter-infusion intervals, escalation of intake, and reinstatement responding on the active lever. Both male and female rats in LgA and ShA conditions escalated oxycodone intake to a similar extent. However, males had higher levels of non-reinforced responding than females under LgA conditions, and females had greater levels of reinstatement responding than males. We then correlated each addiction-related measure listed above with reinstatement responding in males and females and ranked their respective relative contributions. Although the majority of behavioral measures associated with oxycodone self-administration did not show sex differences on their own, when analyzed together using partial least squares regression, their relative contributions to reinstatement were sex-dependent. Front-loading behavior was calculated to have the highest relative contribution to reinstatement in both sexes, with long and short inter-infusion intervals having the second greatest contribution in females and males, respectively. Our results demonstrate sex differences in some oxycodone self-administration measures. More importantly, we demonstrate that a sex- dependent constellation of self-administration behaviors can predict the magnitude of reinstatement, which holds great promise for relapse prevention in people.
Identifiants
pubmed: 36505730
doi: 10.3389/fnbeh.2022.1035350
pmc: PMC9731098
doi:
Types de publication
Journal Article
Langues
eng
Pagination
1035350Subventions
Organisme : NIDA NIH HHS
ID : K00 DA053527
Pays : United States
Informations de copyright
Copyright © 2022 Guha, Alonso-Caraballo, Driscoll, Babb, Neal, Constantino, Lintz, Kinard and Chartoff.
Déclaration de conflit d'intérêts
The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
Références
Am J Psychiatry. 2005 Aug;162(8):1423-31
pubmed: 16055763
Biol Psychiatry. 2019 Dec 1;86(11):848-856
pubmed: 31326085
Horm Behav. 2010 Jun;58(1):44-56
pubmed: 19818789
Science. 1998 Oct 9;282(5387):298-300
pubmed: 9765157
Science. 2004 Aug 13;305(5686):1014-7
pubmed: 15310906
Psychopharmacology (Berl). 2017 Mar;234(6):977-987
pubmed: 28127624
Psychopharmacology (Berl). 2001 Jun;156(1):98-107
pubmed: 11465640
Nat Protoc. 2007;2(11):2987-95
pubmed: 18007634
Psychol Rev. 1987 Oct;94(4):469-92
pubmed: 3317472
Psychopharmacology (Berl). 2021 Apr;238(4):1029-1046
pubmed: 33404740
Pharmacol Rev. 2016 Apr;68(2):242-63
pubmed: 26772794
J Neurosci. 2012 Aug 22;32(34):11600-9
pubmed: 22915104
Pharmacol Rev. 2002 Mar;54(1):1-42
pubmed: 11870259
Addict Biol. 2021 May;26(3):e12973
pubmed: 33078503
Physiol Behav. 2015 May 1;143:58-69
pubmed: 25708277
Neuropsychopharmacology. 2020 Jul;45(8):1251-1262
pubmed: 31747681
Annu Rev Neurosci. 1995;18:463-95
pubmed: 7605071
Front Neuroendocrinol. 2014 Jan;35(1):111-39
pubmed: 24287074
J Neurosci. 2016 May 25;36(21):5748-62
pubmed: 27225765
Clin Psychol Rev. 2018 Dec;66:12-23
pubmed: 29174306
Int J Neuropsychopharmacol. 2019 Jun 3;22(6):383-393
pubmed: 30989210
Neuropsychopharmacology. 2014 Jan;39(2):254-62
pubmed: 24121188
Psychopharmacology (Berl). 2009 May;203(4):677-84
pubmed: 19043694
Behav Pharmacol. 1999 Sep;10(5):513-21
pubmed: 10780257
Neuropharmacology. 2019 Jun;151:189-194
pubmed: 30880124
Pharmacol Res. 2019 Jan;139:158-165
pubmed: 30465850
Neuropsychopharmacology. 2022 Jun;47(7):1285-1291
pubmed: 35338255
J Clin Psychol. 1971 Oct;27(4):455-6
pubmed: 5115648
Neuropsychopharmacology. 2017 Apr;42(5):1126-1135
pubmed: 28025975
Neuropsychopharmacology. 2020 Apr;45(5):770-779
pubmed: 31905372
Addiction. 2001 Jan;96(1):103-14
pubmed: 11177523
Pharmacol Biochem Behav. 1989 Feb;32(2):527-31
pubmed: 2727015
J Neurosci. 2006 Jun 14;26(24):6450-7
pubmed: 16775132
Psychopharmacology (Berl). 2005 Jul;180(3):473-90
pubmed: 15731896
Psychopharmacology (Berl). 2010 Jun;210(2):241-52
pubmed: 20372879
Neuropsychopharmacology. 2019 Feb;44(3):465-477
pubmed: 30293087
Neuropsychopharmacology. 2000 Apr;22(4):413-21
pubmed: 10700660
Prog Brain Res. 2016;224:25-52
pubmed: 26822352
J Neurosci. 2013 Dec 4;33(49):19384-92
pubmed: 24305833
Biol Psychiatry. 2016 Jan 1;79(1):39-46
pubmed: 25747744
Br J Pharmacol. 2022 Jan;179(2):227-241
pubmed: 34505281
Biol Psychiatry. 2020 Jan 1;87(1):44-53
pubmed: 31400808
Neuropsychopharmacology. 2019 Jan;44(1):166-183
pubmed: 29946108
Psychopharmacology (Berl). 2020 Nov;237(11):3369-3381
pubmed: 32990768
Biol Psychiatry. 2009 May 15;65(10):863-8
pubmed: 18639867
Front Pharmacol. 2014 May 27;5:116
pubmed: 24904419